Caprolactam Market Dynamics Report (Recent Commodity Market Intelligence)

I. Price Trend
- Current Price: As of May 22, 2026, the spot average price of caprolactam in the East China market stood at RMB 12,175 per metric ton (delivered on acceptance basis).
- Price Fluctuation: Since May 1, 2026, caprolactam prices have exhibited a continuous downward trend—declining from RMB 12,887.50/ton on May 1 to RMB 12,175/ton on May 22, representing a decline of 5.53%.
- Historical Comparison: Compared with 2025, current prices remain relatively low. The annual average price of caprolactam in the East China market in 2025 was RMB 9,263.51/ton; however, intra-year price volatility was significant, with a high–low spread reaching RMB 3,150/ton.

II. Supply–Demand Landscape
- Supply Side:
- Several caprolactam production units that had undergone maintenance shutdowns recently resumed operations, including Hunan Petrochemical and Fujian Yongrong, gradually restoring supply volumes.
- Industry operating rates have declined slightly but remain at a moderate level; nonetheless, market availability continues to tighten.
- Demand Side:
- Downstream PA6 (polyamide 6) markets face sluggish sales, with overall inventories remaining elevated. Buyers exhibit limited tolerance for high raw material prices, resulting in weak procurement intent.
- PA6 chip prices continue declining, narrowing the price spread versus caprolactam—and in some cases even resulting in price inversion—leading to strong resistance among polymerization enterprises.

III. Cost Support
- Benzene Market: Benzene is currently undergoing inventory drawdown. Supported by resilient crude oil prices, benzene is expected to remain stable in the short term within the range of RMB 8,500–8,700/ton.
- Auxiliary Raw Materials: Prices of key auxiliary materials—including synthetic ammonia and hydrogen peroxide—have declined to varying degrees, further weakening cost support for caprolactam.

IV. Market Developments
- Upstream–Downstream Negotiation: Upstream producers, supported by cost floors and relatively tight supply, demonstrate strong willingness to stabilize prices. Conversely, downstream buyers—constrained by weak demand—exert strong downward pricing pressure, resulting in a stalemate between the two sides.
- Corporate Strategies: Some caprolactam producers have implemented output reductions to address supply–demand imbalances, pushing industry operating rates down to relatively low levels.

Analysis & Outlook

I. Short-Term Price Trend
- Narrowing Downside Potential: Due to the ongoing standoff between upstream and downstream players, the downside potential for caprolactam prices has gradually narrowed. Prices are likely to trade in a narrow, slightly weak range in the near term.
- Limited Cost Support: Although benzene prices remain relatively firm, falling auxiliary material prices and insufficient overall cost support continue to exert downward pressure on caprolactam prices.

II. Medium–Long-Term Supply–Demand Outlook
- Slowing Supply Growth: Caprolactam capacity growth in 2026 is projected to decelerate to 1.96%, signaling a marked slowdown in expansion and entry into a phase of low-speed capacity growth.
- Sustained Demand Growth: Downstream PA6 is expected to add 765,000 tons of new capacity in 2026, representing an 8.79% year-on-year growth rate. If these projects come online as scheduled, they will generate approximately 780,000 tons of incremental caprolactam demand.
- Improving Supply–Demand Balance: Although the PA6 sector itself faces intensified supply–demand imbalances—keeping its operating rates low—the underlying demand for caprolactam remains robust, suggesting continued improvement in the overall caprolactam supply–demand balance.

Forecast

I. Price Forecast
- Short-Term Price: Caprolactam prices are expected to continue fluctuating within a narrow range, with limited downside risk—but also insufficient upward momentum.
- Medium–Long-Term Price: As supply–demand fundamentals improve and cost support gradually strengthens, caprolactam prices may experience a recovery-driven uptrend over the medium to long term. However, the extent of any increase may be constrained by inadequate upstream cost support and relatively strong downstream bargaining power.

II. Strategic Recommendations
- Producers: Should closely monitor market developments and cost dynamics, and prudently adjust production planning and sales strategies to mitigate risks arising from supply–demand imbalances and price volatility.
- Downstream Users: May consider moderately increasing inventory levels in anticipation of future price increases, while enhancing communication and collaboration with upstream suppliers to jointly maintain market stability.
- Investors: Are advised to carefully assess both market risks and return expectations, and allocate assets rationally to hedge against volatility-related risks.